UBI Pharma Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 477.564 million compared to TWD 479.559 million a year ago. Operating loss was TWD 153.818 million compared to TWD 238.175 million a year ago. Net loss was TWD 74.225 million compared to TWD 241.880 million a year ago. Basic loss per share was TWD 0.86 compared to TWD 3.01 a year ago.